For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    By product type
    Proteins and Peptides
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

New Directions in Immuno-oncology: Response and Resistance

Related

  • Immuno-oncology at abcam
    • Pathway: the tumor microenvironment and the immune system
      • Pathway: Cancer immunotherapy and the PD-1 /PD-L1 checkpoint
        • Solutions for multiplex imaging the TME
          • View our webinar library
            • Register for upcoming immuno-oncology events

              Watch on demand the live sessions held in February 2021  


              Description:

              Immuno-oncology, the approach of harnessing the immune system to help fight cancer, has emerged in the last decade as one of the fastest-growing areas in cancer research with hundreds of potential treatments under investigation. As the field has accelerated, the issue of immuno-oncology resistance has arisen and is now a key area of high unmet medical need for cancer researchers to understand and address. 

              Watch this series of on-demand sessions dedicated to the latest breakthroughs in cell therapies, resistance to immunotherapies (tumor microenvironment and overcoming acquired resistance), and multiplex technologies. Gain insights into approaches impacting the field with talks from thought leaders across industry and academia.

              Live sessions:​

              • Cell therapies: Super charging the immune system
              • Resistance to immunotherapies: Turning cold into hot - firing up the TME
              • Resistance to immunotherapies: Mechanisms to overcome acquired resistance
              • Multiplex technologies to advance immuno-oncology and oncology discoveries

              Cell therapies: Super charging the immune system


              Webinar objectives

              • Describe Hedgehog signaling in immune cells during the anti-tumor response
              • Explain HLA-E and NKG2A as a novel immune checkpoint axis in bladder cancer
              • Discuss the engineering of CAR T cells with improved persistence and resistance to the solid tumor microenvironment​


              Speakers

              • Maike de la Roche, University of Cambridge, UK​
                • Hedgehog signaling in immune cells during the anti-tumor response
                • Timestamp: 8:08 - 31:25
              • Uriel Moreno, Johnson & Johnson, USA
                • Plasticity of natural killer cells in the tumor microenvironment
                • Timestamp: 32:35 - 1:00:30
              • Deborah Moore-Lai, Abcam, USA
                • Proteins and reagents for cell therapy research
                • Timestamp: 1:01:20 - 1:19:10
              • Amir Horowitz, Icahn School of Medicine at Mount Sinai, USA
                • HLA-E and NKG2A as a novel immune checkpoint axis in bladder cancer
                • Timestamp: 1:20:21 - 1:55:33

              Resistance to immunotherapies: Turning cold into hot - firing up the TME


              Webinar objectives

              • Discover how hypoxia drives tumor immune suppression and immunotherapy resistance
              • Discuss overcoming resistance to STING-induced anti-tumour immunity
              • Utilize in vivo labeling system to identify and isolate cells from the metastatic niche


              Speakers

              • Michael Curran, MD Anderson Cancer Center, USA​
                • Hypoxia drives tumor immune suppression and immunotherapy resistance
                • Timestamp: 2:35 - 37:02
              • Andrew Mellor, Newcastle University, UK​
                • ​Overcoming resistance to STING-induced anti-tumour immunity
                • Timestamp: 38:06 - 1:06:45
              • Luigi Ombrato, Barts Cancer Institute - Queen Mary University of London, UK
                • ​Tumor microenvironment de-construction: a tool to study inter-cellular interactions in the niche
                • Timestamp: 1:07:40 - 1:32:30

              Resistance to immunotherapies: Mechanisms to overcome acquired resistance


              Webinar objectives

              • Discuss new directions for selective pathogenic roles for IDO1 in metastatic vasculogenesis and retinopathy
              • Identify novel tools for integrated screens with single-cell readouts
              • Review predictive biomarkers for immunotherapy response and resistance

              ​Speakers

              • George Prendergast, The Lankenau Institute for Medical Research, USA
                • IDO/TDO targeting for cancer therapy: the path forward
                • Timestamp: 7:20 - 34:12
              • Mari Mino-Kenudson, Massachusetts General Hospital, USA
                • Primary and acquired resistance to immunotherapies in lung cancer: Mechanisms and predictive biomarkers
                • Timestamp: 35:25 - 59:15
              • Benjamin Izar, Columbia University, USA
                • Pooled screens with multi-modal single-cell profiling to define mechanisms of cancer immune evasion
                • Timestamp: 1:00:27 - 1:28:17
              • Rüdiger Greinert, Elbekliniken Stade/Buxtehude, Germany
                • Use of a miRNA (FirePlex) assay for biomarker identification in clinical settings
                • ​Timestamp: 1:29:16 - 1:58:05

              Multiplex technologies to advance immuno-oncology and oncology discoveries


              Webinar objectives

              • Discuss key technology and technical hurdles for personalized medicine in immuno-oncology
              • Review method for fluorescent multiplex immunostaining and related digital image analysis
              • Discover how multiplexed imaging can be used to infer organization of immune cells in human tumors​

              Speakers

              • Joe Yeong, A*STAR, Singapore
                • The era beyond PD-L1: What can we do to help oncologists colleagues and patients further for personalized medicine?
                • Timestamp: 8:20 - 38:57
              • Leeat Keren, Weizmann Institute of Science, Israel
                • Love thy neighbor – unraveling the tumor-immune microenvironment using multiplexed imaging
                • Timestamp: 39:57 - 59:50
              • Jacques Fieschi, HalioDx, France
                • Bridging translation research to clinical application: Brightplex, a validated multiplex IHC technology to spatially explore the TME
                • Timestamp: 1:00:37 - 1:25:23
              • Adrien Guillot, Charité - Universitätsmedizin Berlin, Germany
                • Multiplex immunohistochemistry on a single archival formalin-fixed paraffin-embedded tissue section
                • Timestamp: 1:26:30 - 1:47:08
                  ​

              Contact

              ​Have a question? Please contact the Abcam Events Team.


              Get resources and offers direct to your inbox Sign up
              A-Z by research area
              • Cancer
              • Cardiovascular
              • Cell biology
              • Developmental biology
              • Epigenetics & Nuclear signaling
              • Immunology
              • Metabolism
              • Microbiology
              • Neuroscience
              • Signal transduction
              • Stem cells
              A-Z by product type
              • Primary antibodies
              • Secondary antibodies
              • Biochemicals
              • Isotype controls
              • Flow cytometry multi-color selector
              • Kits
              • Loading controls
              • Lysates
              • Peptides
              • Proteins
              • Slides
              • Tags and cell markers
              • Tools & Reagents
              Help & support
              • Support
              • Make an Inquiry
              • Protocols & troubleshooting
              • Placing an order
              • RabMAb products
              • Biochemical product FAQs
              • Training
              • Browse by Target
              Company
              • Corporate site
              • Investor relations
              • Company news
              • Careers
              • About us
              • Blog
              Events
              • Tradeshows
              • Conferences
              International websites
              • abcam.cn
              • abcam.co.jp

              Join with us

              • LinkedIn
              • facebook
              • Twitter
              • YouTube
              • Terms of sale
              • Website terms of use
              • Cookie policy
              • Privacy policy
              • Legal
              • Modern slavery statement
              © 1998-2023 Abcam plc. All rights reserved.